Quick Answer
Orchestra BioMed Holdings, Inc. reported Stockholders Equity of $53.57 million for fiscal year 2025.
Orchestra BioMed Holdings, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $53.57M | +62.5% |
| 2024 | $32.96M | -51.6% |
| 2023 | $68.04M | +1079.8% |
| 2022 | -$6.94M | -76.2% |
| 2021 | -$3.94M | -10.6% |
| 2020 | -$3.56M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $43.74M | -5.4% | +14726.8% |
| June 30, 2025 | $295.0K | -99.3% | -98.2% |
| March 31, 2025 | $16.86M | -70.5% | -48.9% |
| December 31, 2024 | $32.96M | -51.6% | -28.7% |
| September 30, 2024 | $46.22M | -42.0% | +4.7% |
| June 30, 2024 | $44.12M | -50.7% | -22.8% |
| March 31, 2024 | $57.19M | -42.7% | -16.0% |
| December 31, 2023 | $68.04M | +29.5% | -14.6% |
- Orchestra BioMed Holdings, Inc. showed an increase of +62.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2020–2025 period, Orchestra BioMed Holdings, Inc.’s stockholders equity has grown by 1603.4% (from -$3.56 million to $53.57 million).
- The most recent figure is from Orchestra BioMed Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: